Intervention

HDM1002 400 mg

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting2

Common conditions1

Lead sponsors shown1

Clinical trials

3 shown

Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes MellitusNCT07193459 · 2025-08-12

A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusNCT07082114 · 2025-07-14

To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes MellitusNCT06481085 · 2024-06-27

Common conditions

Type 2 Diabetes3

Leading sponsors

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3

Trial status mix

RECRUITING2

COMPLETED1

Phase mix

PHASE32

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.